Linda Stein Gold MD,a William P. Werschler MD,b Jennifer Mohawk PhDc
aDepartment of Dermatology, Henry Ford Hospital, Detroit, MI bDepartment of Medicine/Dermatology, University of Washington, Seattle, WA cGalderma Laboratories, L.P. Fort Worth, TX
REFERENCES
Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. Jul 2015;172 Suppl 1:3-12.
Landis ET, Davis SA, Taheri A, el al. Top dermatologic diagnoses by age. Dermatology Online Journal. 2014;20(4):22368.
Albuquerque RG, Rocha MA, Bagatin E, et al. Could adult female acne be associated with modern life? Arch Dermatol Res. Oct 2014;306(8):683-688.
Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. Jan 2008;58(1):56-59.
Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. Sep 2009;129(9):2136-2141.
Zeichner JA. Evaluating and treating the adult female patient with acne. J Drugs Dermatol. 2013;12(12):1416-1427.
Dreno B, Thiboutot D, Layton AM, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. Jun 2015;29(6):1096-1106.
Dreno B. Treatment of adult female acne: a new challenge. J Eur Acad Dermatol Venereol. Jun 2015;29 Suppl 5:14-19.
Hassan J, Grogan S, Clark-Carter D, et al. The individual health burden of acne: appearance-related distress in male and female adolescents and adults with back, chest and facial acne. J Health Psychol. Nov 2009;14(8):1105-1118.
Dreno B, Layton A, Zouboulis CC, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. Sep 2013;27(9):1063-1070.
Dreno B, Jean-Decoster C, Georgescu V. Profile of patients with mild-to- moderate acne in Europe: a survey. Eur J Dermatol. Apr 01 2016;26(2):177-184.
Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13-25.
Zaghloul SS, Cunliffe WJ, Good eld MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol. May 2005;152(5):1015-1021.
Jones-Caballero M, Pedrosa E, Penas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology. 2008;217(4):309-314.
Lynde C, Tan J, Andriessen A, et al. A consensus on acne management focused on specific patient features. J Cutan Med Surg. Jul-Aug 2014;18(4):243-255.
Stein Gold L, Weiss J, Rueda MJ, et al. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Am J Clin. Dermatol. Jun 2016;17(3):293-303.
Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. Jul 2003;49(1 Suppl):S1-37.
Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. May 2009;60(5 Suppl):S1-50.
Thiboutot D, Pariser DM, Egan N, et al. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol. Feb 2006;54(2):242-250.
Weiss J, Stein Gold L, Leoni M, et al. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment-- Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel. J Drugs Dermatol. Dec 2015;14(12):1427-1435.
Pariser DM, Rich P, Cook-Bolden FE, Korotzer A. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris. J Drugs Dermatol. Sep 2014;13(9):1083-1089.
Draelos ZD, Carter E, Maloney JM, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. Mar 2007;56(3):439 e431-410.
Berg M, Lindberg M. Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol. Aug 2011;25(8):969-972.
Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. May 1989;14(3):194-198.
Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J. Am Acad Dermatol. Oct 1999;41(4):577-580.
Moradi Tuchayi S, Alexander TM, Nadkarni A, et al. Interventions to increase adherence to acne treatment. Patient Prefer Adherence. 2016;10:2091-2096.
Friedman A, Waite K, Brandt S, Meckfessel MH. Accelerated Onset of Action and Increased Tolerability in Treating Acne With a Fixed-Dose Combination Gel. J Drugs Dermatol. Feb 1 2016;15(2):231-236.
Patel MLS, Chien AL, Xu H, et al. Improvement in atrophic acne scars by topical adapalene 0.3% gel is associated with induction of procollagen I and III. Society of Investigative Dermatology; 2014; Albuquerque, NM.
Bourdes V. Poster presented at 23rd World Congress of Dermatology, Vancouver, Canada. 2015.
Vega BJ, A.; Michel, S. Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene. J Eur Acad Dermatol Venereol. 2002;16 (Suppl 1):123-124.
Tenaud I, Khammari A, Dreno B. In vitro modulation of TLR-2, CD1d and IL- 10 by adapalene on normal human skin and acne in ammatory lesions. Exp Derm. Jun 2007;16(6):500-506.
Zuliani T, Khammari A, Chaussy H, et al. Ex vivo demonstration of a synergistic effect of Adapalene and benzoyl peroxide on in ammatory acne lesions. Exp Derm. Oct 2011;20(10):850-853.
Stein Gold LB, H.; Rueda, M.J.; Kerrouche, N.; et al. Adapalene-benozyl peroxide gel is efficacious and safe in adult female acne with a profile comparable to that seen in teen-aged females. 2016;9:23-29.
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our cookie policy | Continue
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.